Our values

Delivering clinical insight

Lab21 supports healthcare providers and the pharmaceutical and biotechnology industries with technically advanced testing services.

The Lab21 team’s experience and know-how is coupled with a rapidly growing portfolio of molecular and viral diagnostics, plus pharmacogenetic and patient profiling tests, which all use cutting-edge technology. This unique combination adds value to early stage drug development, clinical trials and regulatory processes in pharmaceutical industry – and directly to clinicians or healthcare providers as they treat and monitor patients.

As we move towards truly personalised healthcare, the Lab21 team can contribute today - delivering high-quality information on drugs and patients that provides real clinical insight.

Our vision

Looking ahead to personalised healthcare

We can look forward to healthcare that will be more effective and efficient – for individual patients, for the systems that deliver care, and for the companies that develop drugs.

Profiling will predict the risk of certain diseases or conditions developing, and we will reach a more complete understanding of the impact an individual’s genetic make-up, lifestyle choices and environmental factors can have on disease progression and response to therapy.

Our focus

Today, Lab21 customers can access tests and services across a broad range. Spearhead products such as pharmacogenetic tests, gold-standard viral diagnostics, cytochrome P450 genotyping and viral resistance mapping give us an edge in the market – and customers the data they need to support the increasing regulatory, financial or efficiency burdens inherent in today’s healthcare system.

Our delivery

The commercial team can help define a testing programme relevant to our customer’s needs, for example:

• physicians looking to diagnose disease, prescribe the optimum dose, monitor the efficacy of a particular therapy, or assess the appearance of resistance.
• healthcare providers charged with delivering a cost-effective service who are looking to outsource certain areas of diagnostic testing.
• discovery scientists who need to characterise a virus, assess prospective drug candidates, or understand potential resistance.
• clinical trials specialists looking to genotype a trials population, assess their pharmacogenetics, or monitor patients undergoing therapy.

And our experienced scientific team, working in our laboratories will deliver – on time and on budget